Inventiva (IVEVF) Depreciation & Amortization (CF) (2019 - 2022)
Inventiva (IVEVF) posted Depreciation & Amortization (CF) of $647857.1 for Q4 2022, down 2.22% on a QoQ basis from $662584.1 in Q3 2022, and up 6.05% year-over-year from $610880.5 in Q4 2021.
Analysis
Inventiva (IVEVF) Depreciation & Amortization (CF) (2019 - 2022) Analysis & Trends
Inventiva has reported Depreciation & Amortization (CF) for 4 years, with the latest figure at $647857.1 in Q4 2022.
- On a quarterly basis, Depreciation & Amortization (CF) rose 6.05% year-over-year to $647857.1 in Q4 2022; TTM through Jun 2024 was $647857.1, a 50.56% decrease from a year earlier, with the FY2025 full-year figure at $3.8 million, down 32.46% from the prior year.
- Depreciation & Amortization (CF) was $647857.1 for Q4 2022 at Inventiva, down from $662584.1 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $795257.3 in Q4 2020, with the low at $276982.4 in Q2 2021.
- Average Depreciation & Amortization (CF) over 4 years is $527278.8, with a median of $610880.5 recorded in 2021.
- The sharpest annual moves came in 2020 and 2021: Depreciation & Amortization (CF) gained 22.4% in 2020, then retreated 23.8% in 2021.
- Over 4 years, Depreciation & Amortization (CF) stood at $649743.1 in 2019, then gained by 22.4% to $795257.3 in 2020, then decreased by 23.18% to $610880.5 in 2021, then gained by 6.05% to $647857.1 in 2022.
- The last three Depreciation & Amortization (CF) figures came in at $647857.1 (Q4 2022), $662584.1 (Q3 2022), and $610880.5 (Q4 2021), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.53 Bn | 625.77 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 442.27 Bn | 435.70 Bn | 12.70 Bn | - |
| 3 | Merck | 366.81 Bn | 359.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.37 Bn | 147.67 Bn | 10.94 Bn | 1.62 Bn |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | 3.97 Bn |
| 7 | Revolution Medicines | 44.12 Bn | 44.12 Bn | - | - |
| 8 | Incyte | 25.49 Bn | 20.95 Bn | 1.57 Bn | 26.48 Mn |
| 9 | United Therapeutics | 21.55 Bn | 18.89 Bn | 683.80 Mn | 24.20 Mn |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 647,857.08 |
| Sep 22, 2022 | 662,584.15 |
| Dec 31, 2021 | 610,880.49 |
| Jun 30, 2021 | 276,982.43 |
| Mar 31, 2021 | 366,695.78 |
| Dec 31, 2020 | 795,257.33 |
| Jun 30, 2020 | 363,481.84 |
| Mar 31, 2020 | 372,027.45 |
| Dec 31, 2019 | 649,743.06 |